Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dose-Responsive Effect of Polydextrose on Whole Gut Transit Time (PDX-Transit)

This study has been terminated.
(Slow recruitment)
Sponsor:
Collaborator:
Sprim Advanced Life Sciences
Information provided by (Responsible Party):
Danisco
ClinicalTrials.gov Identifier:
NCT01540669
First received: February 23, 2012
Last updated: January 21, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2013
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)